We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The company has an impressive earnings surprise history, with the average beat being 2.9%. In the last reported quarter, its earnings of $2.06 per share missed the Zacks Consensus Estimate of $2.08 by 1%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Let’s see how things have shaped up for Nordson this earnings season.
Factors to Note Ahead of NDSN’s Q2 Results
The Industrial Precision Solutions segment’s results are expected to put up a weak show due to lower demand for polymer processing and industrial coatings product lines. The consensus mark for the segment’s revenues is pegged at $323 million, indicating a 12% decrease from the year-ago figure.
Decreased demand for medical interventional product lines due to continued destocking is likely to have weighed on the Medical and Fluid Solutions segment in the to-be-reported quarter. Softness in electronics processing and x-ray product lines is likely to have hurt the Advanced Technology Solutions segment’s sales.
The escalating cost of sales poses a threat to NDSN’s bottom line. High input costs are expected to have pushed up the cost of sales, which is likely to have reflected in its margins.
The company’s international presence exposes it to the risk of adverse currency fluctuations, which are likely to have hurt its performance.
However, the acquisition of Atrion Corporation, which expanded Nordson’s medical offerings in the infusion and cardiovascular therapies market, is expected to support its results. In August 2023, NDSN acquired ARAG Group and its subsidiaries, which boosted its core capabilities in precision dispensing technology and helped it expand into the rapidly growing precision agriculture end-market. This acquisition is expected to aid results.
The Zacks Consensus Estimate for the company’s fiscal second-quarter revenues is pegged at $673.6 million, indicating an increase of 3.5% from the year-ago quarter’s figure. The consensus estimate for adjusted earnings is pegged at $2.36 per share, indicating a 0.9% decrease from the year-ago quarter’s number.
Our proven model does not conclusively predict an earnings beat for NDSN this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: NDSN has an Earnings ESP of 0.00%, as both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at $2.36. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: NDSN presently carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Performance of Other Companies
AZZ Inc. (AZZ - Free Report) came out with quarterly earnings of $0.98 per share in the second quarter of fiscal 2025 (ended March 2025), beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share in the prior year.
AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with the year-ago revenues of $366.5 million.
Valmont Industries (VMI - Free Report) reported revenues of $969.31 million in the first quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share were $4.32 for the same period compared with $4.32 a year ago.
The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate pegged at $4.24 per share.
Pentair plc (PNR - Free Report) came out with quarterly earnings of $1.11 per share in the first quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share in the previous year.
Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Nordson Gears Up to Report Q2 Earnings: What's in the Offing?
Nordson Corporation (NDSN - Free Report) is scheduled to release second-quarter fiscal 2025 (ended April 30) results on May 28, after market close.
The company has an impressive earnings surprise history, with the average beat being 2.9%. In the last reported quarter, its earnings of $2.06 per share missed the Zacks Consensus Estimate of $2.08 by 1%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Let’s see how things have shaped up for Nordson this earnings season.
Factors to Note Ahead of NDSN’s Q2 Results
The Industrial Precision Solutions segment’s results are expected to put up a weak show due to lower demand for polymer processing and industrial coatings product lines. The consensus mark for the segment’s revenues is pegged at $323 million, indicating a 12% decrease from the year-ago figure.
Decreased demand for medical interventional product lines due to continued destocking is likely to have weighed on the Medical and Fluid Solutions segment in the to-be-reported quarter. Softness in electronics processing and x-ray product lines is likely to have hurt the Advanced Technology Solutions segment’s sales.
The escalating cost of sales poses a threat to NDSN’s bottom line. High input costs are expected to have pushed up the cost of sales, which is likely to have reflected in its margins.
The company’s international presence exposes it to the risk of adverse currency fluctuations, which are likely to have hurt its performance.
However, the acquisition of Atrion Corporation, which expanded Nordson’s medical offerings in the infusion and cardiovascular therapies market, is expected to support its results. In August 2023, NDSN acquired ARAG Group and its subsidiaries, which boosted its core capabilities in precision dispensing technology and helped it expand into the rapidly growing precision agriculture end-market. This acquisition is expected to aid results.
The Zacks Consensus Estimate for the company’s fiscal second-quarter revenues is pegged at $673.6 million, indicating an increase of 3.5% from the year-ago quarter’s figure. The consensus estimate for adjusted earnings is pegged at $2.36 per share, indicating a 0.9% decrease from the year-ago quarter’s number.
Nordson Corporation Price and EPS Surprise
Nordson Corporation price-eps-surprise | Nordson Corporation Quote
Earnings Whispers for NDSN
Our proven model does not conclusively predict an earnings beat for NDSN this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: NDSN has an Earnings ESP of 0.00%, as both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at $2.36. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: NDSN presently carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Performance of Other Companies
AZZ Inc. (AZZ - Free Report) came out with quarterly earnings of $0.98 per share in the second quarter of fiscal 2025 (ended March 2025), beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share in the prior year.
AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with the year-ago revenues of $366.5 million.
Valmont Industries (VMI - Free Report) reported revenues of $969.31 million in the first quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share were $4.32 for the same period compared with $4.32 a year ago.
The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate pegged at $4.24 per share.
Pentair plc (PNR - Free Report) came out with quarterly earnings of $1.11 per share in the first quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share in the previous year.
Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion.